Defining the benefits of euglycemia in the hospitalized patient

Journal of Hospital Medicine

Volumn 2, Issue SUPPL. 1, 2007, Pages 5-12

  Braithwaite, Susan S ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NONE   (United States)

Author keywords

Algorithms; Critical care; Hospital hyperglycemia; Hypoglycemia; Outcomes

Indexed keywords

BICARBONATE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; POTASSIUM;

CAPILLARY ENDOTHELIUM; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTINUOUS HEMOFILTRATION; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENZYME ACTIVATION; GLYCEMIC CONTROL; HEART ARRHYTHMIA; HEART INFARCTION; HEART SURGERY; HOSPITAL PATIENT; HOST RESISTANCE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFECTION; INTELLECTUAL IMPAIRMENT; LENGTH OF STAY; MORTALITY; PATIENT MONITORING; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; SEPSIS; TREATMENT OUTCOME;

BLOOD GLUCOSE; HOSPITALISTS; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); POSTOPERATIVE CARE;

EID: 34248675764     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.155     Document Type: Review

References (93)

1. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17(1):107-124.
2. Wachtel TJ, Tetu-Mouradjian LM, Goldman DL, Ellis SE, O'Sullivan PS. Hyperosmolarity and acidosis in diabetes mellitus: a three-year experience in Rhode Island. J Gen Intern Med. 1991:495-502.
3. Wachtel TJ, Silliman RA, Lamberton P. Prognostic factors in the diabetic hyperosmolar state. J Am Geriatr Soc. 1987;35: 737-741.
4. Wachtel TJ, Silliman RA, Lamberton P. Predisposing factors for the diabetic hyperosmolar state. Arch Intern Med. 1987; 147:499-501.
5. Wachtel TJ. The diabetic hyperosmolar state. Clin Geriatr Med. 1990;6:797-806.
6. Leibovici L, Samra Z, Konisberger H, Kalter-Leibovici O, Pitlik SD, Drucker M. Bacteremia in adult diabetic patients. Diabetes Care. 1991;14(2):89-94.
7. Leibovici L, Yehezkelli, Porter A, Regev A, Krauze I, Harell D. Influence of diabetes mellitus and glycaemic control on the characteristics and outcome of common infections. Diabet Med. 1996:457-463.
8. Bertoni AG, Saydah S, Brancati FL. Diabetes and the risk of infection-related mortality in the U.S. Diabetes Care. 2001; 24:1044-1049.
9. Fischer KF, Lees JA, Newman JH. Hypoglycemia in hospitalized patients. N Engl J Med. 1986;315:1245-1250.
10. Braithwaite SS, Buie MM, Thompson CL, et al. Hospital hypoglycemia: not only treatment but also prevention. Endocr Pract. 2004;10(suppl 2):71-80.
11. Hirsch IB. Effect of insulin therapy on nonglycemic variables during acute illness. Endocr Pract. 2004;10(suppl 2):63-70.
12. Le Roith D. Molecular mechanisms by which metabolic control may improve outcomes. Endocr Pract. 2004;10(suppl 2):57-62.
13. Dandona P, Mohanty P, Chaudhuri A, Garg R, Aljada A. Insulin infusion in acute illness. J Clin Invest. 2005; 115:2069-2072.
14. Vanhorebeek I, Langouche L, Van den Berghe G. Intensive insulin therapy in the intensive care unit: update on clinical impact and mechanisms of action. Endocr Pract. 2006; 12(suppl 3):14-21.
15. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345:1359-1367.
16. Bagdade JD, Stewart M, Walters E. Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes. Diabetes. 1978;27:677-681.
17. Bagdade JD, Root RK, Bulger RJ. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes. 1974;23(1):9-15.
18. Naghibi M, Smith RP, Baltch AL, et al. The effect of diabetes mellitus on chemotactic and bactericidal activity of human polymorphonuclear leukocytes. Diabetes Res Clin Pract. 1987;4:27-35.
19. Alexiewicz JM, Kumar D, Smogorzewski M, Klin M, Massry SG. Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med. 1995;123:919-924.
20. McManus LM, Bloodworth RC, Prihoda TJ, Blodgett JL, Pinckard RN. Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. J Leukoc Biol. 2001;70:395-404.
21. Rassias Al, Givan AL, Marrin CAS, Whalen K, Pahl J, Yeager MP. Insulin increases neutrophil count and phagocytic capacity after cardiac surgery. Anesth Analg. 2002;94:1113-1119.
22. Walrand S, Guillet C, Boirie Y, Vasson MP. In vivo evidences that insulin regulates human polymorphonuclear neutrophil functions. J Leukoc Biol. 2004;76:1104-1110.
23. Zeng G, Quon MJ. Insulin- stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest. 1996;98:894-898.
24. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest. 1994;94:1172-1179.
25. Aljada A, Dandona P. Effect of insulin on human aortic endothelial nitric oxide synthase. Metabolism. 2000;49(2): 147-50.
26. Alonso D, Radomski MW. Nitric oxide, platelet function, myocardial infarction and reperfusion therapies. Heart Fail Rev. 2003;8(1):47-54.
27. Langouche L, Vanhorebeek I, Vlasselaers D, et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest. 2005;115:2277-2286.
28. Steinberg HO, Tarshoby M, Monestel R, et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest. 1997;100:1230-1239.
29. Dandona P, Aljada A, Mohanty P, et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab. 2001;86: 3257-3265.
30. Dandona P, Aljada A, Mohanty P. The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia. 2002;45:924-930.
31. Dandona P, Aljada A, Chaudhuri A, Bandyopadhyay A. The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes. J Clin Endocrinol Metab. 2003;88:2422-2429.
32. Dandona P, Aljada A, Bandyopadhyay A. The potential therapeutic role of insulin in acute myocardial infarction in patients admitted to intensive care and in those with unspecified hyperglycemia. Diabetes Care. 2003;26:516-519.
33. Jeschke MG, Klein D, Herndon DN. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg. 2004; 239:553-560.
34. Chaudhuri A, Janicke D, Wilson MF, et al. Anti-inflammatory and profibrinolytic effect of insulin in acute ST- segment-elevation myocardial infarction. Circulation. 2004; 109:849-854.
35. Weiser M. Relation between the duration of remission and hyperglycemia in induction chemotherapy for acute lymphocytic leukemia. Cancer. 2004;100:1179-1185.
36. Thomas M, Mathew T, Russ G, Rao M, Moran J. Early peri-operative glycaemic control and allograft rejection in patients with diabetes mellitus: a pilot study. Transplantation. 2001;72:1321-1324.
37. Pomposelli JJ, Baxter JK, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. J Parenter Enteral Nutr. 1998;22(2):77-81.
38. Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma. 2004;56:1058-1062.
39. Vriesendorp TM, Morelis QJ, DeVries JH, Legemate DA, Hoekstra JBL. Early post-operative glucose levels are an independent risk factor for infection after peripheral vascular surgery. A retrospective study. Eur J Vasc Endovasc Surg. 2004;5:520-525.
40. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67:352-362.
41. Furnary AP, Braithwaite SS. Effects on outcome of in-hospital transition from intravenous insulin infusion to subcutaneous therapy. Am J Cardiol. 2006;98:557-564.
42. Kao LS, Knight MT, Lally KP, Mercer DW. The impact of diabetes in patients with necrotizing soft tissue infections. Surg Infect. 2005;6:427-438.
43. Joshi N, Caputo G, Weitekamp M, Karchmer A. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341: 1906-1912.
44. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003;26:510-513.
45. Malmberg K, Rydén L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
46. Malmberg K, Ryden L, Hamstent A, et al. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. Eur Heart J. 1996;17:1337-1344.
47. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ. 1997;314:1512-1515.
48. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;109: 1497-1502.
49. Investigators C-ETG. Effect of Glucose- Insulin-Potassium Infusion on Mortality in Patients With Acute ST-Segment Elevation Myocardial Infarction: The CREATE-ECLA Randomized Controlled Trial. JAMA. 2005;293:437-446.
50. Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:650-661.
51. Cheung NW, Wong VW, McLean M. The Hyperglycemia: Intensive Insulin Infusion In Infarction (HI-5) Study: A randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care. 2006;29:765-770.
52. Hirsch IB. Inpatient diabetes: review of data from the cardiac care unit. Endocr Pract. 2006;12(suppl 3):27-34.
53. Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract. 2004;10(suppl 2):46-52.
54. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354: 449-461.
55. Zerr KJ, Furnary AP, Grunkemeier GL. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997;63:356-361.
56. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007-1021.
57. Furnary AP, Wu Y. Clinical effects of hyperglycemia in the cardiac surgery population: the Portland diabetic project. Endocr Pract. 2006;12(suppl 3):22-26.
58. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79:992-1000.
59. Krinsley JS. Decreased mortality of critically ill patients with the use of an intensive glycemic management protocol. Mayo Clin Proc. 2003;78:1471-1478.
60. Bruno A, Levine SR, Frankel MR, et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke. Trial. Neurology. 2002;59:669-74.
61. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke. Trial (GIST). Stroke. 1999;30:793-799.
62. Gray CS, Hildreth Al, Alberti GKMM, O'Connell JE. Post-stroke hyperglycemia: natural history and immediate management. Stroke. 2004;35(l):122-126.
63. Bruno A, Saha C, Williams LS, Shankar R. IV insulin during acute cerebral infarction in diabetic patients. Neurology. 2004;62:1441-1442.
64. Garg R, Chaudhuri A, Munschauer F, Dandona P. Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke. 2006;37(1):267-273.
65. Bhatia A, Cadman B, Mackenzie I. Hypoglycemia and cardiac arrest in a critically ill patient on strict glycemic control. Anesth Analg. 2006;102:549-551.
66. Watkinson P, Barber VS, Young JD. Strict glucose control in the critically ill. Br Med J. 2006;332:865-866.
67. Malhotra A. Intensive Insulin in Intensive Care. N Engl J Med. 2006;354:516-518.
68. Inzucchi SE, Rosenstock J. Counterpoint: Inpatient glucose management: a premature call to arms? Diabetes Care. 2005; 28:976-979.
69. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003;290:2041-2047.
70. Kagansky N, Levy S, Rimon E, et al. Hypoglycemia as a predictor of mortality in hospitalized elderly patients. Arch Intern Med. 2003;163:1825-1829.
71. Vriesendorp TM, van Santen S, DeVries JH, et al. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med. 2006;34:96-101.
72. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978-982.
73. De Block C, Manuel YKB, Van Gaal L, Rogiers P. Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring. Diabetes Care. 2006;29: 1750-1756.
74. Braithwaite SS, Godara H, Song H-J, Rock P. No patient left behind: evaluation and design of intravenous insulin infusion algorithms. Endocr Pract. 2006;12(suppl 3):72-78.
75. Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27:553-591.
76. Baldwin D, Villanueva G, McNutt R, Bhatnagar S. Eliminating Inpatient Sliding-Scale Insulin: A reeducation project with medical house staff. Diabetes Care. 2005;28:1008-1011.
77. Schoeffler JM, Rice DAK, Gresham DG. 70/30 Insulin algorithm versus sliding scale insulin. Ann Pharmacother. 2005; 39:1606-1609.
78. Campbell KB, Braithwaite SS. Hospital management of hyperglycemia. Clin Diabetes. 2004;22(2):81-88.
79. Magee MF, Clement S. Subcutaneous insulin therapy in the hospital setting: issues, concerns, and implementation. Endocr Pract. 2004;10(suppl 2):81-88.
80. Thompson CL, Dunn KC, Menon MC, Kearns LE, Braithwaite SS. Hyperglycemia in the hospital. Diabetes Spectr. 2005;18(1):20-27.
81. Hirsch IB. Insulin Analogues. N Engl J Med. 2005;352:174-183.
82. Leahy JL. Insulin management of diabetic patients on general medical and surgical floors. Endocr Pract. 2006;12(suppl 3):86-90.
83. Vora AC, Saleem TM, Polomano RC, et al. Improved peri-operative glycemic control by continuous insulin infusion under supervision of an endocrinologist does not increase costs in patients with diabetes. Endocr Pract. 2004;10(2):112-118.
84. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004;10(suppl 2):21-33.
85. Ku SY, Sayre CA, Hirsch IB, Kelly JL. New insulin infusion protocol improves blood glucose control in hospitalized patients without increasing hypoglycemia. J Qual Patient Saf. 2005;31:141-147.
86. Lien LF, Spratt SE, Zinta Woods Z, Osborne KK, Feinglos M. Optimizing hospital use of intravenous insulin therapy: improved management of hyperglycemia and error reduction with a new nomogram. Endocr Pract. 2005;11:240-253.
87. Davis ED, Harwood K, Midgett L, Mabrey M, Lien LF. Implementation of a new intravenous insulin method on intermediate-care units in hospitalized patients. Diabetes Educ. 2005;31:818-823.
88. Goldberg PA, Roussel MG, Inzucchi SE. Clinical results of an updated insulin infusion protocol in critically ill patients. Diabetes Spectr. 2005;18(3):188-191.
89. Davidson PC, Steed RD, Bode BW. Glucommander: A computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care. 2005;28:2418-2423.
90. Osburne RC, Cook CB, Stockton L, et al. Improving hyperglycemia management in the intensive care unit: preliminary report of a nurse-driven quality improvement project using a redesigned insulin infusion algorithm. Diabetes Educ. 2006;32:394-403.
91. Braithwaite SS, Edkins R, MacGregor KL, et al. Performance of a dose-defining insulin intusion protocol among trauma service ICU admissions. Diabetes Technol Ther. 2006;8:476-488.
92. Lonergan T, Le Compte A, Willacy M, et al. A simple insulin-nutrition protocol for tight glycemic control in critical illness: development and protocol comparison. Diabetes Technol Ther. 2006;8:191-206.
93. Plank J, Haas W, Rakovac I, et al. Evaluation of the impact of chiropodist care in the secondary prevention of foot ulcerations in diabetic subjects. Diabetes Care. 2003;26:1691-1695.